Wan et al. [78] found bispecific PD-1 and PD-L1 inhibitor not only induced T cells but also NK cells to be more active and cytotoxic in high-grade serous ovarian cancer, while neither monospecific antibody induced NK cell activation. This evidence concerns the gene PDCD1 and ovarian serous adenocarcinoma.